ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 131,41
0,69%
Dow Jones
39 056,39
0,44%
DAX
18 498,38
0,32%
Brent Oil
83,56
0,84%
Bitcoin
61 175,06
-1,86%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioSig Technologies Inc (BSGM)

  7. BioSig Technologies Inc (BSGM) Actualités

BSGM

BioSig Technologies (BSGM)

BioSig Technologies Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BSGM
DateHeureSourceTitreSymboleSociété
07/05/202419h49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BSGMBioSig Technologies Inc
03/05/202418h22GlobeNewswire Inc.BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent  NASDAQ:BSGMBioSig Technologies Inc
30/04/202420h03GlobeNewswire Inc.BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective ImmediatelyNASDAQ:BSGMBioSig Technologies Inc
04/04/202417h35GlobeNewswire Inc.BioSig Engages Consulting Firm for Business Model StrategiesNASDAQ:BSGMBioSig Technologies Inc
05/03/202402h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BSGMBioSig Technologies Inc
20/02/202416h00GlobeNewswire Inc.BioSig Announces Reduction of its WorkforceNASDAQ:BSGMBioSig Technologies Inc
14/02/202421h31Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BSGMBioSig Technologies Inc
06/02/202414h30GlobeNewswire Inc.BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient CasesNASDAQ:BSGMBioSig Technologies Inc
02/02/202423h18Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BSGMBioSig Technologies Inc
31/01/202417h15GlobeNewswire Inc.BioSig Announces Reverse Stock SplitNASDAQ:BSGMBioSig Technologies Inc
30/01/202414h30GlobeNewswire Inc.BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core StrategyNASDAQ:BSGMBioSig Technologies Inc
16/01/202422h15Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BSGMBioSig Technologies Inc
05/01/202422h16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BSGMBioSig Technologies Inc
29/12/202319h37Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:BSGMBioSig Technologies Inc
28/12/202322h05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BSGMBioSig Technologies Inc
06/12/202320h20GlobeNewswire Inc.BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024NASDAQ:BSGMBioSig Technologies Inc
06/12/202300h17Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:BSGMBioSig Technologies Inc
01/12/202315h13Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BSGMBioSig Technologies Inc
21/11/202323h32Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BSGMBioSig Technologies Inc
14/11/202323h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BSGMBioSig Technologies Inc
13/11/202322h30GlobeNewswire Inc.BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BSGMBioSig Technologies Inc
07/11/202314h00GlobeNewswire Inc.BioSig Appoints Global MedTech Leader Fred Hrkac as New Executive VPNASDAQ:BSGMBioSig Technologies Inc
03/11/202321h32Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BSGMBioSig Technologies Inc
03/11/202321h31Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BSGMBioSig Technologies Inc
02/11/202313h00GlobeNewswire Inc.BioSig’s New PURE EP™ Subscription Model Adopted by Mayo Clinic-Phoenix for World-Class Cardiac CareNASDAQ:BSGMBioSig Technologies Inc
01/11/202313h30GlobeNewswire Inc.BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio Covering Digital Signal Processing Technology and AINASDAQ:BSGMBioSig Technologies Inc
15/09/202322h52Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BSGMBioSig Technologies Inc
24/08/202316h30GlobeNewswire Inc.BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for HospitalsNASDAQ:BSGMBioSig Technologies Inc
23/08/202314h30GlobeNewswire Inc.BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, CustomizationsNASDAQ:BSGMBioSig Technologies Inc
22/08/202314h00GlobeNewswire Inc.BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient CasesNASDAQ:BSGMBioSig Technologies Inc
 Showing the most relevant articles for your search:NASDAQ:BSGM

Dernières Valeurs Consultées

EU
ACA
Credit Agricole
EU
AI
Air Liquide
EU
ML
Michelin
EU
RI
Pernod Ricard
FTSE
UKX
FTSE 100
NASDAQ
GOOGL
Alphabet
NYSE
JPM
JP Morgan Chase
EU
BNP
BNP Paribas
EU
DG
Vinci
NYSE
NKE
Nike
COIN
ETHUSD
Ethereum
EU
AF
Air FranceKLM
NASDAQ
AAPL
Apple
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés